Designing the Next Generation of
Psycho-targeted Biotherapeutics
3 Primary Breakthroughs For The Treatment Of Mental Health Issues.
IP Protected Bio synthetic pathway for candidate production
Ability to Manufacture and conduct invitro & invivo efficacy testing and conduct human
clinical trial
Portfolio of psycho-targeted biotherapeutics
Pioneering the design of psycho-targeted therapeutics for the improvement of mental and neurological health
Psybio has developed a portfolio of bio-medical chemistry development psycho-targeted compounds for the potential treatment for mental and neurological health.
Psybio was formed to create psycho-targeted biotherapeutics
Dedicated Research and Development Laboratory
Miami University, Oxford, OH
Manufacturing Partners
Curia Global
Biose Industrie
Lawrence Berkley National Lab
Analyst
Coverage
Maxim Group
Noble Capital Markets
World Class Team Of Experts
Combined leadership experience with over 50 years in the Biotech Industry
Chief Medical Officer (needs copy here)
Excellent Board of Directors ( needs copy here )
